Jason P. Kelly - 31 Aug 2026 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Reporting relationship: Title - Chief Operations and Innovation Officer
Issuer ticker: INSP
Reported as of: 31 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 20:29:01 UTC
Prior SEC filing: 11 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Bryan Phillips, Attorney-in-Fact for Jason P. Kelly

Key filing fact

Jason P. Kelly filed Form 4 for Inspire Medical Systems, Inc. (INSP) on 02 Sep 2026.

Key facts

This page summarizes Jason P. Kelly's Form 4 filing for Inspire Medical Systems, Inc. (INSP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 20:29.

Change

Previous filing in this sequence was filed on 11 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002057473 Primary reporting owner

Kelly Jason P

Relationship: Title - Chief Operations and Innovation Officer
Address: C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Jason P. Kelly
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSP transaction

Common Stock

Award

Transaction value
Shares: +6,350
Change %: +33%
Price: $0.000000^*
Shares after: 25,335
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

SEC remarks

Title - Chief Operations and Innovation Officer